KKR (KKR) has been rounding up private lenders offering a combination of senior and subordinated debt to help fund its proposed purchase of Karo Healthcare, bypassing traditional banks, Bloomberg reported on Wednesday, citing people with knowledge of the matter.
Apollo Global Management (APO) is leading the group of private lenders that also includes Goldman Sachs (GS), JPMorgan Chase (JPM) and Jefferies (JEF) along with privately held CVC and KKR's private credit unit, the sources said.
KKR announced plans to acquire Stockholm-based Karo on April 9, buying the specialty pharmaceuticals company from EQT as Karo continues to expand beyond its Scandinavian roots and shift its strategic focus to consumer health care. The companies did not disclose financial details of the transaction but the Bloomberg report said KKR has arranged about 1.1 billion euros ($1.25 billion) in funding for the deal.
KKR and all of the lenders did not immediately respond to requests from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 106.76, Change: +4.48, Percent Change: +4.38
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。